Pauline Merrill to Evidence-Based Medicine
This is a "connection" page, showing publications Pauline Merrill has written about Evidence-Based Medicine.
Connection Strength
0.031
-
Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial. Lancet. 2016 Sep 17; 388(10050):1183-92.
Score: 0.031